The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others.
Musculoskeletal Drugs Global Market Size
The global musculoskeletal drugs market was valued at $130.10 billion in 2017. North America was the largest geographic region in the musculoskeletal disorders drugs market in 2017, accounting for $41 billion or 31.5% market share. The USA was the largest country in the market in 2017, accounting for $19.4 billion or 14.9% market share.
Musculoskeletal Drugs Global Market Trend
Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis. In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.
Musculoskeletal Drugs Global Market Segmentation
The musculoskeletal drugs market is segmented into Antirheumatic Drugs, Muscle Relaxants, and Others.
Antirheumatic Drugs are used in the treatment of rheumatoid arthritis to slow down the progression of disease.
Muscle Relaxants are drugs that act on the central nervous system to reduce pain associated with strains, sprains and muscle injuries.
Others include drugs used in treatment of osteoarthritis, analgesics, and immunosupressives used in treatment of various musculoskeletal disorders.
The major players in the global musculoskeletal drugs market are F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Abbott Laboratories Inc., and Daiichi Sankyo Company, Limited.
The countries covered in the global musculoskeletal drugs market are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.